Top Deals
Jan. 10, 2013
Personalized medicine companies to grow with advances in industry
Personalized medicine companies purchased and sold themselves this past year as potential benefits in the health industry became clear through lowered genome sequencing costs and the development of alternative treatments.
Daily Journal Staff Writer
The personalized medicine industry experienced strong interest from both pharmaceutical giants and early-stage investors last year, and observers expect that excitement in the sector to remain strong in the coming year.
Personalized medicine is a growing industry in which companies are developing alternative medical treatments for individuals based on their genetic code.
In Februar...
For only $95 a month (the price of 2 article purchases)
Receive unlimited article access and full access to our archives,
Daily Appellate Report, award winning columns, and our
Verdicts and Settlements.
Or
$795 for an entire year!
Or access this article for $45
(Purchase provides 7-day access to this article. Printing, posting or downloading is not allowed.)
Already a subscriber?
Sign In